Aquatic environmental assessment of the top 25 English prescription pharmaceuticals OAH Jones, N Voulvoulis, JN Lester Water research 36 (20), 5013-5022, 2002 | 990 | 2002 |
Pharmaceuticals: a threat to drinking water? OA Jones, JN Lester, N Voulvoulis TRENDS in Biotechnology 23 (4), 163-167, 2005 | 693 | 2005 |
Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom JP Bound, N Voulvoulis Environmental health perspectives 113 (12), 1705-1711, 2005 | 686 | 2005 |
Household hazardous waste in municipal landfills: contaminants in leachate RJ Slack, JR Gronow, N Voulvoulis Science of the total environment 337 (1-3), 119-137, 2005 | 656 | 2005 |
Human pharmaceuticals in the aquatic environment a review OAH Jones, N Voulvoulis, JN Lester Environmental technology 22 (12), 1383-1394, 2001 | 583 | 2001 |
Endocrine disrupting pesticides: implications for risk assessment R McKinlay, JA Plant, JNB Bell, N Voulvoulis Environment international 34 (2), 168-183, 2008 | 574 | 2008 |
Human pharmaceuticals in wastewater treatment processes OA H. Jones, N Voulvoulis, JN Lester Critical reviews in environmental science and technology 35 (4), 401-427, 2005 | 530 | 2005 |
The EU Water Framework Directive: From great expectations to problems with implementation N Voulvoulis, KD Arpon, T Giakoumis Science of the Total Environment 575, 358-366, 2017 | 501 | 2017 |
Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies JP Bound, N Voulvoulis Chemosphere 56 (11), 1143-1155, 2004 | 438 | 2004 |
Cadmium levels in Europe: implications for human health J Pan, JA Plant, N Voulvoulis, CJ Oates, C Ihlenfeld Environmental geochemistry and health 32, 1-12, 2010 | 432 | 2010 |
Distribution and sources of polycyclic aromatic hydrocarbons in the middle and lower reaches of the Yellow River, China G Li, X Xia, Z Yang, R Wang, N Voulvoulis Environmental pollution 144 (3), 985-993, 2006 | 368 | 2006 |
Alternative antifouling biocides N Voulvoulis, MD Scrimshaw, JN Lester Applied organometallic chemistry 13 (3), 135-143, 1999 | 327 | 1999 |
Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment OAH Jones, N Voulvoulis, JN Lester Critical reviews in toxicology 34 (4), 335-350, 2004 | 314 | 2004 |
Water reuse from a circular economy perspective and potential risks from an unregulated approach N Voulvoulis Current Opinion in Environmental Science & Health 2, 32-45, 2018 | 288 | 2018 |
The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment OAH Jones, N Voulvoulis, JN Lester Environmental Pollution 145 (3), 738-744, 2007 | 273 | 2007 |
Education for sustainable development: A systemic framework for connecting the SDGs to educational outcomes V Kioupi, N Voulvoulis Sustainability 11 (21), 6104, 2019 | 271 | 2019 |
Food waste co-digestion with sewage sludge–realising its potential in the UK E Iacovidou, DG Ohandja, N Voulvoulis Journal of environmental management 112, 267-274, 2012 | 257 | 2012 |
Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment JP Bound, N Voulvoulis Water Research 40 (15), 2885-2892, 2006 | 241 | 2006 |
Household disposal of pharmaceuticals and perception of risk to the environment JP Bound, K Kitsou, N Voulvoulis Environmental toxicology and pharmacology 21 (3), 301-307, 2006 | 215 | 2006 |
Managing the effects of multiple stressors on aquatic ecosystems under water scarcity. The GLOBAQUA project A Navarro-Ortega, V Acuna, A Bellin, P Burek, G Cassiani, ... Science of the Total Environment 503, 3-9, 2015 | 211 | 2015 |